Global Biologics CDMO (Contract Development and Manufacturing Organization) Market 2021

USD 450

Product Type

Industry Statistics

Release Date

15 March 2021

Region

Global

Release Year

2021

Table of Contents
    Add a header to begin generating the table of contents

    Description

    The global biologics CDMO (contract development and manufacturing organization) market in terms of revenue is set to grow by US$ 22 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 20.3% during the forecast period, according to data and analytics company StrategyHelix.

    The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for biologics CDMO (contract development and manufacturing organization). The global biologics CDMO (contract development and manufacturing organization) market is segmented on the basis of type, service, cell culture. By type, it is categorized into gene therapy CDMO (contract development and manufacturing organization), and others. By service, the biologics CDMO (contract development and manufacturing organization) market is divided into drug product, and drug substance. Based on cell culture, the biologics cdmo (contract development and manufacturing organization) market is divided into mammalian, and microbial.

    The report has profiled some of the key players of the market such as Boehringer Ingelheim Biopharmaceuticals GmbH, Lonza Group AG, Thermo Fisher Scientific Inc..

    The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the biologics CDMO (contract development and manufacturing organization) market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


    Report Scope

    Type: gene therapy CDMO (contract development and manufacturing organization), and others
    Service: drug product, and drug substance
    Cell culture: mammalian, and microbial
    Years Considered: this report covers the period 2017 to 2027


    Key Benefits for Stakeholders

    Get a comprehensive picture of the global biologics CDMO (contract development and manufacturing organization) market
    Pinpoint growth sectors and trends for investment
    Understand what the future of the global biologics CDMO (contract development and manufacturing organization) market looks like
    Identify the competitive landscape and window of opportunity


    Table of Contents

    1. Market Definition
    2. Research Methodology
    3. Market Data & Outlook
    3.1 Market Value
    3.2 Market Value Forecast
    4. Biologics CDMO (Contract Development and Manufacturing Organization) Market by Type
    4.1 Gene Therapy Cdmo (Contract Development And Manufacturing Organization)
    4.2 Others
    5. Biologics CDMO (Contract Development and Manufacturing Organization) Market by Service
    5.1 Drug Product
    5.2 Drug Substance
    6. Biologics CDMO (Contract Development and Manufacturing Organization) Market by Cell Culture
    6.1 Mammalian
    6.2 Microbial
    7. Company Profiles
    7.1 Boehringer Ingelheim Biopharmaceuticals GmbH
    7.2 Lonza Group AG
    7.3 Thermo Fisher Scientific Inc.
    8. Appendix
    8.1 About StrategyHelix
    8.2 Disclaimer


    StrategyHelix Black LOGO

    REQUEST SAMPLE

    Please fill out our form and we will get back to you.

    Global Biologics CDMO (Contract Development and Manufacturing Organization) Market 2021

    StrategyHelix Black LOGO

    CUSTOM RESEARCH

    Custom projects can be researched to match your unique needs.

    Global Biologics CDMO (Contract Development and Manufacturing Organization) Market 2021

    login